Thursday, January 22, 2026

Trump Administration Applauds Itself for Rx Access Agreements, But Will They Help Patients?

›
By:  Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy In May 2025, President Donald J. Trump signed an executive order requi...
Thursday, January 15, 2026

Trump Administration Pushes Two New Rebate Models, But Will They Help Patients?

›
By: Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy The Centers for Medicare and Medicaid Services (CMS) has released infor...
Thursday, January 8, 2026

In Memoriam: Edward "Rick" Macsata

›
By:  Brandon M. Macsata , CEO, ADAP Advocacy The ADAP Blog has a longstanding tradition of presenting facts about policy issues, typically i...
Thursday, December 18, 2025

2025: A Look Back on Our Advocacy

›
By:  Brandon M. Macsata , CEO, ADAP Advocacy ADAP Advocacy inches toward the conclusion of an active year in advocacy, one defined by chaos,...
Thursday, December 11, 2025

We Humbly Thank You, Ranier

›
By:  Brandon M. Macsata , ADAP CEO Since January 2022, Ranier Simons has delivered the weekly ADAP Blog to thousands of stakeholders across ...
Thursday, December 4, 2025

Alternative Funding Programs for Prescription Drugs Are Putting Patient Lives at Risk

›
By:  Ranier Simons , ADAP Blog Guest Contributor As part of ADAP Advocacy’s continued spotlight on the dangers of counterfeit prescription d...
Wednesday, November 26, 2025

Counterfeit Drug Rings Increasingly Peddling Fraudulent HIV, Cancer, and GLP-1 Medications

›
By:  Ranier Simons , ADAP Blog Guest Contributor Healthcare expenditures remain a significant source of contention for many Americans. A rec...